Literature DB >> 28214732

Persistent RNA virus infections: do PAMPS drive chronic disease?

Mary K McCarthy1, Thomas E Morrison2.   

Abstract

Chronic disease associated with persistent RNA virus infections represents a key public health concern. While human immunodeficiency virus-1 and hepatitis C virus are perhaps the most well-known examples of persistent RNA viruses that cause chronic disease, evidence suggests that many other RNA viruses, including re-emerging viruses such as chikungunya virus, Ebola virus and Zika virus, establish persistent infections. The mechanisms by which RNA viruses drive chronic disease are poorly understood. Here, we discuss how the persistence of viral RNA may drive chronic disease manifestations via the activation of RNA sensing pathways.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28214732      PMCID: PMC5474173          DOI: 10.1016/j.coviro.2017.01.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  88 in total

1.  Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics.

Authors:  Wen-Hsuan W Lin; Roger D Kouyos; Robert J Adams; Bryan T Grenfell; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-07       Impact factor: 11.205

2.  Long-Lasting Persistence of Zika Virus in Semen.

Authors:  Sophie Matheron; Eric d'Ortenzio; Isabelle Leparc-Goffart; Bruno Hubert; Xavier de Lamballerie; Yazdan Yazdanpanah
Journal:  Clin Infect Dis       Date:  2016-07-28       Impact factor: 9.079

3.  Late sexual transmission of Zika virus related to persistence in the semen.

Authors:  Jean Marie Turmel; Pierre Abgueguen; Bruno Hubert; Yves Marie Vandamme; Marianne Maquart; Hélène Le Guillou-Guillemette; Isabelle Leparc-Goffart
Journal:  Lancet       Date:  2016-06-07       Impact factor: 79.321

4.  Highly immunostimulatory RNA derived from a Sendai virus defective viral genome.

Authors:  Xiomara Mercado-López; Christopher R Cotter; Won-Keun Kim; Yan Sun; Luis Muñoz; Karla Tapia; Carolina B López
Journal:  Vaccine       Date:  2013-10-05       Impact factor: 3.641

5.  Persistence of West Nile virus in the central nervous system and periphery of mice.

Authors:  Kim K Appler; Ashley N Brown; Barbara S Stewart; Melissa J Behr; Valerie L Demarest; Susan J Wong; Kristen A Bernard
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

6.  Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation.

Authors:  A J Tingle; M Allen; R E Petty; G D Kettyls; J K Chantler
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

7.  Rubella virus and chronic joint disease: is there an association?

Authors:  T J Bosma; J Etherington; S O'Shea; K Corbett; F Cottam; L Holt; J E Banatvala; J M Best
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

8.  Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Authors:  David W Hawman; Kristina A Stoermer; Stephanie A Montgomery; Pankaj Pal; Lauren Oko; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

9.  Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity.

Authors:  Karla Tapia; Won-Keun Kim; Yan Sun; Xiomara Mercado-López; Emily Dunay; Megan Wise; Michael Adu; Carolina B López
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

10.  Human muscle satellite cells as targets of Chikungunya virus infection.

Authors:  Simona Ozden; Michel Huerre; Jean-Pierre Riviere; Lark L Coffey; Philippe V Afonso; Vincent Mouly; Jean de Monredon; Jean-Christophe Roger; Mohamed El Amrani; Jean-Luc Yvin; Marie-Christine Jaffar; Marie-Pascale Frenkiel; Marion Sourisseau; Olivier Schwartz; Gillian Butler-Browne; Philippe Desprès; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  PLoS One       Date:  2007-06-13       Impact factor: 3.240

View more
  15 in total

1.  Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.

Authors:  Jun P Hong; Mary K McCarthy; Bennett J Davenport; Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 2.  A Virus Is a Community: Diversity within Negative-Sense RNA Virus Populations.

Authors:  Lavinia J González Aparicio; Carolina B López; Sébastien A Felt
Journal:  Microbiol Mol Biol Rev       Date:  2022-06-23       Impact factor: 13.044

Review 3.  Long COVID: current status in Japan and knowledge about its molecular background.

Authors:  Akihiro Matsunaga; Shinya Tsuzuki; Shinichiro Morioka; Norio Ohmagari; Yukihito Ishizaka
Journal:  Glob Health Med       Date:  2022-04-30

4.  Chronic Chikungunya Virus Disease.

Authors:  Mary K McCarthy; Bennett J J Davenport; Thomas E Morrison
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 5.  Vertebrate Reservoirs of Arboviruses: Myth, Synonym of Amplifier, or Reality?

Authors:  Goro Kuno; John S Mackenzie; Sandra Junglen; Zdeněk Hubálek; Alexander Plyusnin; Duane J Gubler
Journal:  Viruses       Date:  2017-07-13       Impact factor: 5.048

6.  Lower temperatures reduce type I interferon activity and promote alphaviral arthritis.

Authors:  Natalie A Prow; Bing Tang; Joy Gardner; Thuy T Le; Adam Taylor; Yee S Poo; Eri Nakayama; Thiago D C Hirata; Helder I Nakaya; Andrii Slonchak; Pamela Mukhopadhyay; Suresh Mahalingam; Wayne A Schroder; William Klimstra; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2017-12-27       Impact factor: 6.823

Review 7.  The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis.

Authors:  J Kennedy Amaral; Peter C Taylor; Mauro Martins Teixeira; Thomas E Tem Morrison; Robert T Schoen
Journal:  Viruses       Date:  2019-03-22       Impact factor: 5.048

8.  Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA.

Authors:  Alissa R Young; Marissa C Locke; Lindsey E Cook; Bradley E Hiller; Rong Zhang; Matthew L Hedberg; Kristen J Monte; Deborah J Veis; Michael S Diamond; Deborah J Lenschow
Journal:  PLoS Pathog       Date:  2019-08-29       Impact factor: 6.823

Review 9.  Long-Lived Skin-Resident Memory T Cells Contribute to Concomitant Immunity in Cutaneous Leishmaniasis.

Authors:  Phillip Scott
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-10-01       Impact factor: 9.708

Review 10.  Arboviruses and Muscle Disorders: From Disease to Cell Biology.

Authors:  Claudia Filippone; Vincent Legros; Patricia Jeannin; Valérie Choumet; Gillian Butler-Browne; Jim Zoladek; Vincent Mouly; Antoine Gessain; Pierre-Emmanuel Ceccaldi
Journal:  Viruses       Date:  2020-06-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.